Novartis Fights Zometa Jaw Injury Verdict In 11th Circ.
Novartis Pharmaceuticals Corp. on Tuesday fought a $250,000 verdict in multidistrict litigation over injuries allegedly caused by the bone drug Zometa, arguing to the Eleventh Circuit that it should not be...To view the full article, register now.
Already a subscriber? Click here to view full article